Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
Intra-Cellular Therapies (Nasdaq: ITCI), a biopharmaceutical company specializing in CNS disorder therapeutics, has announced their CEO Sharon Mates will present at three major investor conferences in December 2024. The presentations are scheduled for: the Evercore 7th Annual HealthCONx Conference on December 3 at 10:50 a.m. ET in Miami, the Citi 2024 Global Healthcare Conference on December 4 at 3:15 p.m. ET in Miami, and the Piper Sandler 36th Annual Healthcare Conference on December 5 at 11:30 a.m. ET in New York. Live and archived webcasts will be available on the company's website.
Intra-Cellular Therapies (Nasdaq: ITCI), una società biofarmaceutica specializzata in terapeutiche per disturbi del SNC, ha annunciato che il loro CEO Sharon Mates parteciperà a tre importanti conferenze per investitori a dicembre 2024. Le presentazioni sono programmate per: la 7a Conferenza Annuale HealthCONx di Evercore il 3 dicembre alle 10:50 ET a Miami, la Conferenza Globale sulla Salute 2024 di Citi il 4 dicembre alle 15:15 ET a Miami e la 36a Conferenza Annuale sulla Salute di Piper Sandler il 5 dicembre alle 11:30 ET a New York. Saranno disponibili webcast dal vivo e registrazioni sul sito web della società.
Intra-Cellular Therapies (Nasdaq: ITCI), una compañía biofarmacéutica especializada en terapéuticas para trastornos del SNC, ha anunciado que su CEO Sharon Mates presentará en tres importantes conferencias para inversores en diciembre de 2024. Las presentaciones están programadas para: la 7ª Conferencia Anual HealthCONx de Evercore el 3 de diciembre a las 10:50 a.m. ET en Miami, la Conferencia Global de Salud 2024 de Citi el 4 de diciembre a las 3:15 p.m. ET en Miami, y la 36ª Conferencia Anual de Salud de Piper Sandler el 5 de diciembre a las 11:30 a.m. ET en Nueva York. Las transmisiones web en vivo y grabadas estarán disponibles en el sitio web de la compañía.
Intra-Cellular Therapies (Nasdaq: ITCI)는 CNS 질환 치료제를 전문으로 하는 생명공학 회사로서, CEO 샤론 메이츠가 2024년 12월에 열리는 세 가지 주요 투자자 회의에서 발표할 예정이라고 발표했습니다. 발표 일정은 다음과 같습니다: Evercore 제7회 연례 HealthCONx 컨퍼런스는 12월 3일 오전 10시 50분 ET, 마이애미에서 개최되며, Citi 2024 글로벌 헬스케어 컨퍼런스는 12월 4일 오후 3시 15분 ET, 마이애미에서, 그리고 Piper Sandler 제36회 연례 헬스케어 컨퍼런스는 12월 5일 오전 11시 30분 ET, 뉴욕에서 열립니다. 회사 웹사이트에서는 실시간 및 기록된 웨비나가 제공될 것입니다.
Intra-Cellular Therapies (Nasdaq: ITCI), une entreprise biopharmaceutique spécialisée dans les thérapeutiques des troubles du SNC, a annoncé que sa PDG Sharon Mates interviendra lors de trois grandes conférences pour investisseurs en décembre 2024. Les présentations sont programmées pour : la 7ème Conférence Annuelle HealthCONx d'Evercore le 3 décembre à 10h50 ET à Miami, la Conférence Mondiale de la Santé 2024 de Citi le 4 décembre à 15h15 ET à Miami, et la 36ème Conférence Annuelle de la Santé de Piper Sandler le 5 décembre à 11h30 ET à New York. Des webcasts en direct et enregistrés seront disponibles sur le site web de l’entreprise.
Intra-Cellular Therapies (Nasdaq: ITCI), ein biopharmazeutisches Unternehmen, das sich auf Therapeutika für CNS-Störungen spezialisiert hat, hat bekannt gegeben, dass ihre CEO Sharon Mates auf drei wichtigen Investorenkonferenzen im Dezember 2024 präsentieren wird. Die Präsentationen sind geplant für: die 7. jährliche HealthCONx-Konferenz von Evercore am 3. Dezember um 10:50 Uhr ET in Miami, die Citi-Konferenz für globale Gesundheitsversorgung 2024 am 4. Dezember um 15:15 Uhr ET in Miami und die 36. jährliche Healthcare-Konferenz von Piper Sandler am 5. Dezember um 11:30 Uhr ET in New York. Live- und archivierte Webcasts werden auf der Website des Unternehmens verfügbar sein.
- None.
- None.
BEDMINSTER, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at three upcoming investor conferences:
Evercore 7th Annual HealthCONx Conference
Tuesday, December 3, 2024 at 10:50 a.m. ET in Miami, FL
Citi 2024 Global Healthcare Conference
Wednesday, December 4, 2024 at 3:15 p.m. ET in Miami, FL
Piper Sandler 36th Annual Healthcare Conference
Thursday, December 5, 2024 at 11:30 a.m. ET in New York, NY
A live and achieved webcast of the presentations can be accessed under "Events & Presentations" in the Investors section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.
Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406
FAQ
When is Intra-Cellular Therapies (ITCI) presenting at the Evercore HealthCONx Conference 2024?
Which investor conferences is ITCI attending in December 2024?
How can investors access ITCI's conference presentations in December 2024?
Where will ITCI's presentations take place in December 2024?
